1. Home
  2. KZIA vs MITQ Comparison

KZIA vs MITQ Comparison

Compare KZIA & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • MITQ
  • Stock Information
  • Founded
  • KZIA 1994
  • MITQ N/A
  • Country
  • KZIA Australia
  • MITQ United States
  • Employees
  • KZIA N/A
  • MITQ N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • KZIA Health Care
  • MITQ Telecommunications
  • Exchange
  • KZIA Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • KZIA 6.0M
  • MITQ 8.0M
  • IPO Year
  • KZIA 1999
  • MITQ 2021
  • Fundamental
  • Price
  • KZIA $0.89
  • MITQ $0.73
  • Analyst Decision
  • KZIA Strong Buy
  • MITQ
  • Analyst Count
  • KZIA 2
  • MITQ 0
  • Target Price
  • KZIA $11.50
  • MITQ N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • MITQ 181.3K
  • Earning Date
  • KZIA 03-26-2025
  • MITQ 02-13-2025
  • Dividend Yield
  • KZIA N/A
  • MITQ N/A
  • EPS Growth
  • KZIA N/A
  • MITQ N/A
  • EPS
  • KZIA N/A
  • MITQ N/A
  • Revenue
  • KZIA $1,655,324.00
  • MITQ $18,932,000.00
  • Revenue This Year
  • KZIA $806.89
  • MITQ N/A
  • Revenue Next Year
  • KZIA N/A
  • MITQ N/A
  • P/E Ratio
  • KZIA N/A
  • MITQ N/A
  • Revenue Growth
  • KZIA 248000.00
  • MITQ N/A
  • 52 Week Low
  • KZIA $0.89
  • MITQ $0.42
  • 52 Week High
  • KZIA $15.80
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 28.96
  • MITQ 48.33
  • Support Level
  • KZIA $0.90
  • MITQ $0.68
  • Resistance Level
  • KZIA $1.60
  • MITQ $0.78
  • Average True Range (ATR)
  • KZIA 0.24
  • MITQ 0.05
  • MACD
  • KZIA 0.01
  • MITQ -0.01
  • Stochastic Oscillator
  • KZIA 0.00
  • MITQ 48.86

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: